Literature DB >> 17478448

Loss of caveolin-1 in bronchiolization in lung fibrosis.

Nao Odajima1, Tomoko Betsuyaku, Yasuyuki Nasuhara, Masaharu Nishimura.   

Abstract

Bronchiolization is a key process in fibrosing lung in which the proliferative status of bronchiolar epithelium changes, leading to abnormal epithelial morphology. Within the context that caveolin-1 acts to suppress epithelial proliferation, we postulated that stimulating epithelial injury would lead to caveolin-1 downregulation and encourage proliferation. The present study evaluates the expression of caveolin-1, especially in bronchiolization, in C57BL/6J mice with bleomycin-induced lung fibrosis and in various types of re-epithelialization in human interstitial pneumonias (IPs). Immunohistochemically, levels of caveolin-1 decreased in the bronchiolar epithelium of mice treated with bleomycin. Levels of caveolin-1 mRNA in the whole lung were decreased at 7 and 14 days. Caveolin-1 mRNA was also decreased in laser-capture microdissection- retrieved bronchiolar epithelial cells at 7 days. Among patients with 12 IPs, including four usual IPs (UIPs) and eight nonspecific IPs (NSIPs), whole lung caveolin-1 was significantly decreased compared with 12 controls at both mRNA and protein levels. By scoring immunointensity, caveolin-1 was significantly reduced in bronchiolization and squamous metaplasia as well as in bronchiolar epithelium in 23 IPs (12 UIPs and 11 NSIPs) compared with bronchiolar epithelium from seven controls. These data suggested that loss of caveolin-1 is associated with abnormal re-epithelialization in lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478448     DOI: 10.1369/jhc.7A7203.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

Review 1.  Caveolin-1: a critical regulator of lung injury.

Authors:  Yang Jin; Seon-Jin Lee; Richard D Minshall; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

2.  Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice.

Authors:  Pooja Shivshankar; Christopher Brampton; Shelley Miyasato; Michael Kasper; Victor J Thannickal; Claude Jourdan Le Saux
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-23       Impact factor: 6.914

Review 3.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

4.  Dynamic expression of transformating growth factor-β1 and caveolin-1 in the lung of Bleomycin-induced interstitial lung disease.

Authors:  Yida Xing; Li Wang; Hongjiang Wang; Xiaodan Kong; Libin Zhan
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Caveolins and lung function.

Authors:  Nikolaos A Maniatis; Olga Chernaya; Vasily Shinin; Richard D Minshall
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  A soluble factor (EMMPRIN) in exudate influences knee motion after total arthroplasty.

Authors:  Jun Onodera; Shin Onodera; Eiji Kondo; Tomoko Betsuyaku; Kazunori Yasuda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-17       Impact factor: 4.342

7.  The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties.

Authors:  O Le Saux; K Teeters; S Miyasato; J Choi; G Nakamatsu; J A Richardson; B Starcher; E C Davis; E K Tam; C Jourdan-Le Saux
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-10       Impact factor: 5.464

Review 8.  Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.

Authors:  Francesco Del Galdo; Michael P Lisanti; Sergio A Jimenez
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

9.  Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity.

Authors:  Carol R Gardner; Joshua P Gray; Laurie B Joseph; Jessica Cervelli; Nicole Bremer; Yunjung Kim; Vladimir Mishin; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-25       Impact factor: 4.219

10.  miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.

Authors:  Christian Lacks Lino Cardenas; Imène Sarah Henaoui; Elisabeth Courcot; Christoph Roderburg; Christelle Cauffiez; Sébastien Aubert; Marie-Christine Copin; Benoit Wallaert; François Glowacki; Edmone Dewaeles; Jadranka Milosevic; Julien Maurizio; John Tedrow; Brice Marcet; Jean-Marc Lo-Guidice; Naftali Kaminski; Pascal Barbry; Tom Luedde; Michael Perrais; Bernard Mari; Nicolas Pottier
Journal:  PLoS Genet       Date:  2013-02-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.